capecitabine has been researched along with Vulvar Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beukema, JC; Creutzberg, CL; de Hullu, J; Jürgenliemk-Schulz, I; Lutgens, L; Nout, RA; Peters, M; Rasing, M; Snyers, A; van der Steen-Banasik, E; van der Velden, J; van Triest, B; Westerveld, H; Witteveen, PO | 1 |
1 trial(s) available for capecitabine and Vulvar Neoplasms
| Article | Year |
|---|---|
Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study.
Topics: Adult; Aged; Aged, 80 and over; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Humans; Middle Aged; Prospective Studies; Salvage Therapy; Vulvar Neoplasms | 2021 |